Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma

Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma

<b>Background/Objectives</b>: Anaplastic oligodendrogliomas (AOs) are central nervous system (CNS) World Health Organization (WHO) grade 3 gliomas characterized by isocitrate dehydrogenase (IDH) mutation (m)IDH and 1p/19q codeletion. AOs are typically treated with surgery and chemoradiat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alexander S. Himstead, Jefferson W. Chen, Eleanor Chu, Mari A. Perez-Rosendahl, Michelle Zheng, Sherin Mathew, Carlen A. Yuen
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Biomedicines
Subjects:	vorasidenib anaplastic oligodendroglioma isocitrate dehydrogenase IDH inhibitor glioma
Online Access:	https://www.mdpi.com/2227-9059/13/1/201
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
by: Jorge E. Cortes, et al.
Published: (2025-01-01)

Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients
by: Emre LEVENTOGLU, et al.
Published: (2023-06-01)

Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
by: Liv Cathrine Heggebø, et al.
Published: (2025-01-01)

Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
by: Zhiyang Huang, et al.
Published: (2025-02-01)

Prognostic impact of tumor size on cancer-specific survival for postoperative WHO grade II oligodendroglioma: a SEER-based study
by: Qin Lu, et al.
Published: (2025-02-01)

Preoperative prediction of IDH genotypes and prognosis in adult-type diffuse gliomas: intratumor heterogeneity habitat analysis using dynamic contrast-enhanced MRI and diffusion-weighted imaging
by: Xingrui Wang, et al.
Published: (2025-02-01)

Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated
by: Malcolm F. McDonald, et al.
Published: (2025-01-01)

Using partially shared radiomics features to simultaneously identify isocitrate dehydrogenase mutation status and epilepsy in glioma patients from MRI images
by: Yida Wang, et al.
Published: (2025-01-01)

Magnetic resonance imaging-based deep learning for predicting subtypes of glioma
by: Zhen Yang, et al.
Published: (2025-01-01)

IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
by: Alexander Bray, et al.
Published: (2025-01-01)

IDH-mutant gliomas in children and adolescents - from biology to clinical trials
by: Louise Evans, et al.
Published: (2025-01-01)

Applications of MR Finger printing derived T1 and T2 values in Adult brain: A Systematic review [version 1; peer review: 2 approved]
by: Rajagopal Kadavigere, et al.
Published: (2025-01-01)

Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
by: Ximu Sun, et al.
Published: (2025-02-01)

Anaplastic (undifferentiated) carcinoma of pancreas, an uncommon variant: Diagnosed on endoscopic-guided fine needle aspiration
by: Md Ali Osama, et al.
Published: (2023-07-01)

Cost-effective whole-cell biosynthesis of ursodeoxycholic acid using engineered Escherichia coli with a multienzyme cascade
by: Xue Zhang, et al.
Published: (2025-01-01)

Recent Progress of Genome Study for Anaplastic Thyroid Cancer
by: Jieun Lee, et al.
Published: (2013-06-01)

An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature Review
by: Shu-Cheng Wu, et al.
Published: (2024-01-01)

High p16INK4A expression in glioblastoma is associated with senescence phenotype and better prognosis
by: Soon Sang Park, et al.
Published: (2025-02-01)

TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real‐World Study
by: Hao Xing, et al.
Published: (2025-01-01)

Development of animal models to study aggressive thyroid cancers
by: Shovan Dutta, et al.
Published: (2025-02-01)

TET2-mediated 5-hydroxymethylcytosine of TXNIP promotes cell cycle arrest in systemic anaplastic large cell lymphoma
by: Ziqing Yu, et al.
Published: (2025-01-01)

Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK–IDH2 pathway
by: Hao Huang, et al.
Published: (2023-04-01)

A case report of anaplastic thyroid carcinoma transformed from small papillary carcinoma successfully detected by ultrasonography in its early stage with review of literature
by: Hiroshi Arimitsu, et al.
Published: (2023-11-01)

A Journey into the Complexity of Temporo-Insular Gliomas: Case Report and Literature Review
by: Manuel De Jesus Encarnacion Ramirez, et al.
Published: (2025-01-01)

Recent approaches in the drug research and development of novel antimalarial drugs with new targets
by: Chinnappanna Naveen Kumar Reddy, et al.
Published: (2023-03-01)

Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder
by: Itay Tokatly Latzer, et al.
Published: (2024-04-01)

V-ATPase in glioma stem cells: a novel metabolic vulnerability
by: Alessandra Maria Storaci, et al.
Published: (2025-01-01)

An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene
by: Zita Reisz, et al.
Published: (2025-01-01)

Oncological challenges in GFAP-positive anaplastic meningioma: a case report and literature review
by: Minh Huu Nhat Le, et al.
Published: (2025-01-01)

Primary Breast Anaplastic Large-Cell Lymphoma
by: Min-Hong Wang, et al.
Published: (2023-10-01)

Congenital Oligodendroglioma: Clinicopathologic and Molecular Assessment with Review of the Literature
by: Hope Richard, et al.
Published: (2015-01-01)

Prediction of Survival Outcomes in Patients with Glioma Using Magnetic Resonance Imaging (MRI): A Systematic Review and Meta-Analysis
by: Mingfang Hu, et al.
Published: (2025-01-01)

Beyond Benign: A Case of Subependymal Giant Cell Astrocytomas Provoking Hydrocephalus in Tuberous Sclerosis Complex
by: Antonio Navarro-Ballester, et al.
Published: (2024-05-01)

Research Progress on the Biosynthesis and Applications of Functional Bile Acids
by: ZHENG Miao, CHANG Chao, SU Qi, CAI Chenggang, LU Yuyun, ZHAO Minjie, CAI Haiying
Published: (2025-01-01)

The Predictive Value of Lactate Dehydrogenase for Viral Suppression in Newly Diagnosed People Living With HIV on Antiretroviral Therapy: A Retrospective Cohort Study
by: Jin Y, et al.
Published: (2025-01-01)

Risk Stratification and Adjuvant Chemotherapy for High‐Risk Stage IA Lung Adenocarcinoma: The Unmet Needs
by: Chen Shen, et al.
Published: (2025-01-01)

Machine learning-based prognostic model for patients with anaplastic thyroid carcinoma
by: Yihan Sun, et al.
Published: (2025-01-01)

Synchronous clonally related anaplastic large cell lymphoma and malignant histiocytosis
by: Mirvate Harb, et al.
Published: (2025-01-01)

Editorial: Pediatric CNS tumors in low- and middle-income countries: expanding our understanding
by: Diana S. Osorio, et al.
Published: (2025-01-01)

Cinnamaldehyde impacts key cellular signaling pathways for induction of programmed cell death in high-grade and low-grade human glioma cells
by: Yoo Na Kim, et al.
Published: (2025-01-01)